ChemoCentryx Competitors and Similar CompaniesClear all
ChemoCentryx's competitors and similar companies include Agios Pharmaceuticals.
 ChemoCentryx ChemoCentryx is a biopharmaceutical company commercializing and developing medications for inflammatory and autoimmune diseases and cancer. |  Agios Pharmaceuticals Agios Pharmaceuticals is a biopharmaceutical company discovering and developing therapeutics for cancer metabolism. | |
Founding Date | Founding Date 1997 | Founding Date 2008 |
Type | Type Subsidiary | Type Public |
Tags | ||
Locations | Locations San Carlos, US HQ | Locations Cambridge, US HQ |
Employees | Employees 51 | Employees 53611% increase |
Financial | ||
Revenue (est.) | Revenue (est.) $32.2m (FY, 2021) | Revenue (est.) $54m (FY, 2025) |
Cost of goods | Cost of goods $302k (FY, 2021) | Cost of goods $6.3m (FY, 2025) |
Gross profit | Gross profit $31.9m (FY, 2021) | Gross profit $47.7m (FY, 2025) |
Net income | Net income ($131.8m) (FY, 2021) | Net income ($412.8m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Agios Pharmaceuticals
HQ
Cambridge, US
Employees
536↑ 11% increase
Agios Pharmaceuticals is a biopharmaceutical company discovering and developing therapeutics for cancer metabolism.
View company